Dmitriy Vinarov Email & Phone Number

Dmitriy A. Vinarov, Ph.D., M.B.A. is an Equity Partner with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Vinarov has a broad range of experience in intellectual property law, including patents, trademarks, unfair competition, copyrights, and trade secrets. Dr. Vinarov’s practice at MBHB encompasses primarily all phases of U.S. and foreign patent prosecution, with an emphasis on pharmaceuticals, biological, diagnostics, biochemistry, cell biology, immunology, molecular biology, medical devices, and diagnostics. Dr. Vinarov also provides client counseling in the areas of patentability, freedom-to-operate, infringement, and validity analyses. Dr. Vinarov’s client list includes Fortune 100 companies, mid-size companies, startups, and academic institutions.Prior to joining MBHB, Dr. Vinarov spent nearly ten years leading the development andcommercialization of the cell-free protein expression technology at the Center for Eukaryotic Structural Genomics at the University of Wisconsin-Madison, Ehime University in Matsuyama, Japan, and the CellFree Sciences Co. in Yokohama, Japan. Dr. Vinarov also served as a scientific and business consultant to a variety of companies in the U.S., U.K., and Japan.Dmitriy Vinarov, Ph.D., MBAEquity Partner300 South Wacker Drive, Chicago, Illinois 60606-6709312-913-3368 directvinarov@mbhb.comhttp://www.mbhb.com/attorneys/vinarov/

• 

  Equity Partner

  Mcdonnell Boehnen Hulbert & Berghoff Llp

  Sep 2009 - Present - Chicago, Il

  Dmitriy A. Vinarov is a partner with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Vinarov has a broad range of experience in intellectual property law, including patents, trademarks, unfair competition, copyrights, and trade secrets. Dr. Vinarov’s practice at MBHB encompasses primarily all phases of U.S. and foreign patent prosecution, with an emphasis on pharmaceuticals, biologicals, diagnostics, biochemistry, cell biology, immunology, molecular biology, medical devices, and diagnostics. Dr. Vinarov also provides client counseling in the areas of patentability, freedom-to-operate, infringement, and validity analyses. Dr. Vinarov’s client list includes Fortune 100 companies, mid-size companies, startups, and academic institutions. Prior to joining MBHB, Dr. Vinarov spent nearly ten years leading the development and commercialization of the cell-free protein expression technology at the Center for Eukaryotic Structural Genomics at the University of Wisconsin-Madison, Ehime University in Matsuyama, Japan, and the CellFree Sciences Co. in Yokohama, Japan. Dr. Vinarov also served as a scientific and business consultant to a variety of companies in the U.S., U.K., and Japan.